WO2012021016A3 - Souche de lactobacillus ayant une activité anticancéreuse et une composition d'activité anticancéreuse comprenant celle-ci en tant que substance active - Google Patents

Souche de lactobacillus ayant une activité anticancéreuse et une composition d'activité anticancéreuse comprenant celle-ci en tant que substance active Download PDF

Info

Publication number
WO2012021016A3
WO2012021016A3 PCT/KR2011/005916 KR2011005916W WO2012021016A3 WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3 KR 2011005916 W KR2011005916 W KR 2011005916W WO 2012021016 A3 WO2012021016 A3 WO 2012021016A3
Authority
WO
WIPO (PCT)
Prior art keywords
cancer activity
active ingredient
composition including
including same
lactobacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/005916
Other languages
English (en)
Korean (ko)
Other versions
WO2012021016A2 (fr
WO2012021016A9 (fr
Inventor
박진형
박기범
김희정
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2012021016A2 publication Critical patent/WO2012021016A2/fr
Publication of WO2012021016A3 publication Critical patent/WO2012021016A3/fr
Publication of WO2012021016A9 publication Critical patent/WO2012021016A9/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention est basée sur la découverte d'une activité anticancéreuse dans Lactobacillus de nombreux types de bactéries isolées en observant des souches de fermentation d'origine alimentaire ayant la capacité à fermenter Lactobacillus dans des pommes, et concerne Lactobacillus casei (numéro d'accession KCCM11072) ayant une activité anticancéreuse et la composition d'activité anticancéreuse comprenant celle-ci en tant que substance active, qui peut être utilisée en tant que fourniture médicale ou supplément alimentaire de santé.
PCT/KR2011/005916 2010-08-12 2011-08-11 Souche de lactobacillus ayant une activité anticancéreuse et une composition d'activité anticancéreuse comprenant celle-ci en tant que substance active Ceased WO2012021016A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020100077908A KR20120015644A (ko) 2010-08-12 2010-08-12 항암 활성을 갖는 락토바실러스 균주 및 이를 활성성분으로 포함하는 항암 활성 조성물
KR10-2010-0077908 2010-08-12

Publications (3)

Publication Number Publication Date
WO2012021016A2 WO2012021016A2 (fr) 2012-02-16
WO2012021016A3 true WO2012021016A3 (fr) 2012-05-10
WO2012021016A9 WO2012021016A9 (fr) 2012-06-28

Family

ID=45568066

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/005916 Ceased WO2012021016A2 (fr) 2010-08-12 2011-08-11 Souche de lactobacillus ayant une activité anticancéreuse et une composition d'activité anticancéreuse comprenant celle-ci en tant que substance active

Country Status (2)

Country Link
KR (1) KR20120015644A (fr)
WO (1) WO2012021016A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101910808B1 (ko) * 2016-11-28 2018-10-24 주식회사 쎌바이오텍 유산균 유래 p8 단백질 및 이의 항암 용도
KR102680587B1 (ko) * 2018-05-28 2024-07-03 주식회사 쎌바이오텍 유산균 유래 단백질의 활성 단편 펩타이드 및 이의 용도
KR102457422B1 (ko) * 2022-05-04 2022-10-21 주식회사 메디오젠 프로바이오틱스 혼합균주를 유효성분으로 포함하는 대장암의 예방 또는 치료용 조성물
CN116948916B (zh) * 2023-08-11 2024-06-11 四川大学 一种干酪乳杆菌及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000038058A (ko) * 1998-12-03 2000-07-05 이은선 겨우살이를 발효시키는 신규 유산균인 락토바실러스 카제이 케이 와이 22713
WO2003045405A2 (fr) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
KR100411198B1 (ko) * 2001-03-13 2003-12-18 매일유업주식회사 암 세포주 증식 억제제
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000038058A (ko) * 1998-12-03 2000-07-05 이은선 겨우살이를 발효시키는 신규 유산균인 락토바실러스 카제이 케이 와이 22713
KR100411198B1 (ko) * 2001-03-13 2003-12-18 매일유업주식회사 암 세포주 증식 억제제
WO2003045405A2 (fr) * 2001-11-27 2003-06-05 Bio-K Plus International Inc. Bacteries lactiques et leur usage dans le traitement et la prevention du cancer
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물

Also Published As

Publication number Publication date
WO2012021016A2 (fr) 2012-02-16
KR20120015644A (ko) 2012-02-22
WO2012021016A9 (fr) 2012-06-28

Similar Documents

Publication Publication Date Title
MY172363A (en) Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
RU2013153578A (ru) Полибактериальный препарат с преимуществами для здоровья: c антиоксидантным эффектом, снижением концентрации холестерина, противовоспалительным иммуномодулирующим эффектом и высвобождением биоактивных пептидов, ингибирующих ангиотензин-конвертирующий фермент
WO2009138091A3 (fr) Souche de microorganisme isolée lactobacillus plantarum tensia dsm 21380 en tant que probiotique antimicrobien et antihypertensif, produit alimentaire et composition comprenant ledit microorganisme et utilisation dudit microorganisme pour la préparation d'un médicament hypertensif et procédé pour supprimer des pathogènes et des lactobacilles non utilisés comme levain dans un produit alimentaire
UA46234U (ru) Композиция ингредиентов кваса хлебного
WO2009013709A3 (fr) Biomasse enrichie en zinc, son procédé de préparation, et produits probiotiques, cosmétiques, diététiques et nutraceutiques la comprenant
WO2009142472A3 (fr) Bifidobactérie productrice d'acide folique, composition alimentaire et utilisation de cette bifidobactérie
RU2010147343A (ru) ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
MX355955B (es) Efecto antimicrobiano sinergico.
ATE551419T1 (de) Bakterienstamm mit antiallergischer aktivität sowie getränk, lebensmittel und antiallergikum mit zelle des bakterienstamms
IN2012DN01638A (fr)
UA118250C2 (uk) Застосування молочнокислих бактерій для одержання ферментованих харчових продуктів з підвищеною природною солодкістю
MX2013005192A (es) Cepa de pasteuria novedosa y usos de la misma.
MX2013004343A (es) Cepas texturizadoras de bacterias de acido lactico.
MY159379A (en) Composition for human and/or animal nutrition, uses thereof and yeasts
WO2011162523A3 (fr) Composition pour prévenir ou traiter l'ostéoporose, contenant du ssangwhatang ou un produit fermenté par lactobacillus de celui-ci
WO2009066681A1 (fr) Préparation contenant une bactérie d'acide lactique
MX337716B (es) Preparacion que contiene bacteria de acido lactico.
MX339951B (es) Bacillus subtilis aislado de maiz.
EP1812023B8 (fr) Bacteries lactiques utilisees comme souches probiotiques et compositions les contenant
MX2012007970A (es) Proceso para la preparacion de una biomasa que comprende plantaricina y usos de la misma en el campo medico.
IN2012DN02283A (fr)
WO2012021016A3 (fr) Souche de lactobacillus ayant une activité anticancéreuse et une composition d'activité anticancéreuse comprenant celle-ci en tant que substance active
TW200700074A (en) Inducer of t cell apoptosis
WO2011031145A3 (fr) Fermentation de lait de soja améliorée
WO2011073769A3 (fr) Lignées de bactéries probiotiques productrices d'acide linoléique conjugué et leur utilisation dans le cadre de la préparation d'un produit alimentaire, diététique ou pharmaceutique.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11816632

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11816632

Country of ref document: EP

Kind code of ref document: A2